Regulations.gov document
COVID-19 Public Health Emergency: General Considerations for Pre-IND Meeting Requests for…
Other · FDA-2020-D-1370 · posted May 11, 2020
Key facts
| Document ID | FDA-2020-D-1370-0002 |
|---|---|
| Title | COVID-19 Public Health Emergency: General Considerations for Pre-IND Meeting Requests for COVID-19 Related Drugs and Biological Products Guidance for Industry and Investigators |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2020-D-1370 |
| Posted | May 11, 2020 |
| Comment period opens | May 12, 2020 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: